These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Hyperlipidemia in obesity]. Nishino M, Katsukawa F, Kataoka K. Nihon Rinsho; 1990 Nov 21; 48(11):2572-7. PubMed ID: 2270023 [No Abstract] [Full Text] [Related]
9. Effects of atorvastatin versus probucol on low-density lipoprotein subtype distribution and renal function in hyperlipidemic patients with nondiabetic nephropathy. Yasuda G, Ando D, Hirawa N, Umemura S. Ren Fail; 2010 Jul 21; 32(6):680-6. PubMed ID: 20540635 [Abstract] [Full Text] [Related]
15. Editorial: Is control of hyperlipidaemia important in renal diseases? Med J Aust; 1974 Jul 27; 2(4):115-8. PubMed ID: 4608833 [No Abstract] [Full Text] [Related]
16. Acquired hyperlipidemia (secondary dyslipoproteinemias). Chait A, Brunzell JD. Endocrinol Metab Clin North Am; 1990 Jun 27; 19(2):259-78. PubMed ID: 2192873 [Abstract] [Full Text] [Related]
17. Lipoprotein pattern in end-stage renal disease and following successful renal transplantation. Banyai-Falger S, Gottsauner-Wolf M, Stepan E, Strobl W, Jansen M, Heinz G, Hörl WH, Derfler K. Clin Transplant; 1997 Dec 27; 11(6):545-51. PubMed ID: 9408682 [Abstract] [Full Text] [Related]
18. [Diabetes mellitus and hyperlipidemia]. Uchida N, Shuto Y, Oikawa S. Nihon Rinsho; 2001 Mar 27; 59 Suppl 3():733-7. PubMed ID: 11347163 [No Abstract] [Full Text] [Related]
19. Proteinuria, hyperlipidemia, and the kidney. Hutchison FN. Miner Electrolyte Metab; 1993 Mar 27; 19(3):127-36. PubMed ID: 8232099 [Abstract] [Full Text] [Related]
20. [Causes and risks of hyperlipidemia during dialysis and after renal transplantation]. Verzola A, Perini L, Gatto S, Gilli P, Bedani PL. Recenti Prog Med; 1998 Nov 27; 89(11):590-7. PubMed ID: 9844447 [Abstract] [Full Text] [Related] Page: [Next] [New Search]